Michael Gottlieb
Corporate Officer/Principal en POINT Biopharma, Inc. (United States) .
Cargos activos de Michael Gottlieb
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | 01/01/2020 | - |
Historial de carrera de Michael Gottlieb
Antiguos cargos conocidos de Michael Gottlieb.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| POIT BIOP | Corporate Officer/Principal | 01/06/2021 | 25/11/2021 |
Sanofi Canada, Inc.
 Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Corporate Officer/Principal | 01/12/2017 | 01/09/2019 |
Formación de Michael Gottlieb.
| University of Toronto | Graduate Degree |
| University of Western Ontario | Undergraduate Degree |
Estadísticas
Internacional
| Canadá | 4 |
| Estados Unidos | 3 |
Operativa
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Empresas privadas | 2 |
|---|---|
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Canada, Inc. operates as a global biopharmaceutical company. Its products include prescription, non-prescription and vaccines. The company is headquartered in Laval, Canada. | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Gottlieb
- Experiencia
